Healthcare Triangle, Inc.HCTI
Key ratios
FCF / Sales
-60.3%TTM
2025
-119.0%2024
-9.2%2023
-6.5%
Net margin
-66.3%TTM
2025
-68.2%2024
-51.0%2023
-26.2%
ROA
-20.9%TTM
2025
-49.6%2024
-67.3%2023
-37.2%
ROE
-57.4%TTM
2025
-392.4%2023
-373.7%
Revenue growth
116.4%TTM
2025
18.8%2024
-64.8%2023
-27.6%
Recent news
Healthcare Triangle (Nasdaq: HCTI) Joins Kanzun-ARCB Growth Fund to Build Malaysia-to-US Corridor for AI and Healthcare Companies
Healthcare Triangle to Distribute Minority Interest of Teyame AI Holdings Shares to HCTI Shareholders
Healthcare Triangle Reports 322% Increase in Gross Profit and 158% Increase in Revenue for Q2 2026
HCTI's Teyame Delivers a Full Year of Client Revenue in Six Months; EUR 2 Million in Target
Healthcare Triangle Signs Non-Binding LOI to Acquire 51% of CosmoInnovations, Entering MedTech and Consumer-Health Markets
Healthcare Triangle Completes Share Issuances Relating to Legacy M&A Transactions, Strengthening Nasdaq Listing Compliance
Healthcare Triangle Creates "Purpose Health" to Monetize AI Demand and Accelerate Shareholder Returns
Track HCTI in your journal
Save it to a watchlist, run a reverse DCF, and keep your notes on the company in one place. Free to start.
Figures are sourced from third parties and shown for research only. They may be delayed or incomplete, and nothing on this page is investment advice or a recommendation to buy or sell. Read the full disclaimer